What does Actinium Pharmaceuticals, Inc. do?

Jun 22 2025 06:51 PM IST
share
Share Via
Actinium Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing cancer treatments. As of March 2025, it has a market cap of $44.61 million and reported a net loss of $16 million.
Overview:
Actinium Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company engaged in developing cancer treatments within the Pharmaceuticals & Biotechnology industry. Financial Snapshot: - Most recent Net Profit: -16 Million (Quarterly Results - Mar 2025) - Market-cap: USD 44.61 Million (Micro Cap) Key Metrics: - P/E: NA (Loss Making) - Industry P/E: NA - Dividend Yield: 0.00% - Debt Equity: -2.52 - Return on Equity: -177.13% - Price to Book: 1.74 Contact Details: - Address: 275 Madison Ave Fl 7, NEW YORK NY: 10016-1101 - Tel: 1 646 6773875 - Website: https://www.actiniumpharma.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News